Walnut Creek, CA, United States of America

Andreas Maderna

USPTO Granted Patents = 3 

Average Co-Inventor Count = 12.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Andreas Maderna

Introduction

Andreas Maderna is a notable inventor based in Walnut Creek, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody conjugates. With a total of 3 patents to his name, Maderna's work focuses on therapeutic applications that have the potential to impact patient care.

Latest Patents

Maderna's latest patents include innovations related to anti-ROR1 antibody conjugates. These patents encompass compositions comprising anti-ROR1 antibody conjugates and methods of making and using these conjugates. The present disclosure highlights the specificity of these antibodies for receptor tyrosine kinase orphan receptor 1 (ROR1) and its isoforms and homologs. Additionally, the patents detail methods for producing these antibodies and their applications in therapeutic and diagnostic methods.

Career Highlights

Andreas Maderna is currently associated with Sutro Biopharma, Inc., where he continues to advance his research in antibody drug conjugates. His work is pivotal in developing new treatments that leverage the specificity of antibodies to target cancer cells effectively.

Collaborations

Maderna collaborates with talented professionals in his field, including Alice Yam and Cristina Abrahams. These partnerships enhance the innovative potential of his research and contribute to the success of their projects.

Conclusion

Andreas Maderna's contributions to the field of biotechnology through his patents on anti-ROR1 antibody conjugates exemplify the impact of innovation in therapeutic development. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…